Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
1 other identifier
observational
1,625
1 country
1
Brief Summary
Gastroesophageal Reflux Disease (GERD) is a condition characterized by the reflux of gastric and duodenal contents into the esophagus, primarily manifested by symptoms such as acid regurgitation and heartburn. GERD significantly affects patients' daily lives and health-related quality of life. Prolonged gastroesophageal reflux can lead to repeated irritation of the esophageal mucosa by gastric acid and acidic gastric contents, resulting in the replacement of normal squamous epithelium in the lower esophagus with metaplastic columnar epithelium. This pathological change, known as Barrett's Esophagus (BE), is considered a precancerous lesion for esophageal adenocarcinoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedMarch 13, 2026
March 1, 2026
1.2 years
August 26, 2024
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The prevalence of GERD in Xiamen city
Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disorder in the world. In this study, we will study the incidence of GERD in Xiamen city.
3 months.
The percentage of reflux esophagitis
The percentage of participants diagnosed with reflux esophagitis using endoscopy among patients with baseline symptoms.
3 months.
The percentage of Barrett esophagus
The percentage of paticipants diagnosed with pathological Barrett esophagus using endoscopy monitoring among patients with baseline symptom in gastroenterology department will be calculated.
3 months.
Secondary Outcomes (3)
The life quality of GERD patients who were diagnosed by endoscopy
3 months.
The sensitivity of GERD-Q for diagnosis of GERD
3 months.
The specificity of GERD-Q for diagnosis of GERD
3 months.
Study Arms (1)
Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is a gastrointestinal motility disorder that results from the reflux of stomach contents into the esophagus or oral cavity resulting in symptoms or complications.
Interventions
This concerns a natural history study. No interventions will be used.
Eligibility Criteria
Gastroesophageal reflux disease (GERD) is a common digestive disorder in the general population that primarily affects the esophagus and gastro-duodenum. Due to its prevalence, GERD has a significant impact on quality of life and healthcare costs.
You may qualify if:
- All patients had experienced typical reflux symptoms, i.e., mild heartburn and/or regurgitation symptoms, for at least 2 days per week or moderate/severe reflux symptoms for more than 1 day per week during the previous 3 months and had upper endoscopy examinations in the previous month.
- Cooperate with the questionnaire survey.
- Volunteer and sign the informed consent form.
- Permanent residents in Xiamen.
You may not qualify if:
- Malignant tumor.
- Partial or total gastrectomy.
- Failing to cooperate with the investigation because of the factors such as education level and language intelligence disorder, etc.
- Patients with severe heart, lung, kidney, liver, blood, nerve, endocrine and mental system diseases.
- Patients with mental retardation, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian, 361015, China
Related Publications (2)
Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56. doi: 10.14309/ajg.0000000000001538.
PMID: 34807007RESULTChen Y, Sun X, Fan W, Yu J, Wang P, Liu D, Song M, Liu S, Zuo X, Zhang R, Hou Y, Han S, Li Y, Zhang J, Li X, Ke M, Fang X. Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in China. Nutrients. 2023 Jul 31;15(15):3400. doi: 10.3390/nu15153400.
PMID: 37571337RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wei Jiang, Doctor
Zhongshan Hospital (Xiamen), Fudan University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Chief Physician
Study Record Dates
First Submitted
August 26, 2024
First Posted
September 5, 2024
Study Start
August 1, 2024
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share